Mara Carson
Acute Care · Tampa, FLNPI 1861038044
Payments from drug & device makers
Across 141 payments — averaging $18.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$906
- Pfizer$299
- Novo Nordisk$263
- Sunovion Pharmaceuticals Inc.$174
- Boston Scientific$171
- Eisai Inc.$101
- plus $705 from 24 others
What the payments were for
- Food & beverage$2,620100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $906 |
| Pfizer | 15 | $299 |
| Novo Nordisk | 15 | $263 |
| Sunovion Pharmaceuticals Inc. | 7 | $174 |
| Boston Scientific | 3 | $171 |
| Eisai Inc. | 3 | $101 |
| Indivior Inc. | 4 | $98 |
| Lilly USA, LLC | 5 | $76 |
| AstraZeneca | 3 | $44 |
| Sanofi-aventis U.S. LLC | 3 | $42 |
| Amgen | 2 | $41 |
| Medtronic | 2 | $37 |
| Cranial Technologies, Inc | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Angiodynamics, Inc. | 1 | $29 |
| Mannkind Corporation | 1 | $27 |
| Novartis | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Orexo US, Inc. | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $15 |
| Bayer | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $13 |
| Lucid Diagnostics Inc. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $12 |
How this compares
$2,620 in reported general payments places this provider in the 85th percentile of 1,150 acute care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 29 | $33,792 |
| JardianceEmpagliflozin | 19 | $23,207 |
| MounjaroTirzepatide | 23 | $22,808 |
| EliquisApixaban | 22 | $19,268 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $14,571 |
| MyrbetriqMirabegron | 11 | $11,409 |
| SynthroidLevothyroxine Sodium | 22 | $2,919 |
| Atorvastatin Calcium | 226 | $1,921 |
| Levothyroxine Sodium | 173 | $1,723 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $1,705 |
| Ezetimibe | 31 | $1,213 |
| Lisinopril | 168 | $1,043 |
| Omeprazole | 55 | $1,028 |
| Amlodipine Besylate | 147 | $929 |
| Trazodone Hcl | 48 | $863 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $263 | $33,79229 claims |
| Lilly USA, LLCMounjaro | $76 | $22,80823 claims |
| PfizerEliquis | $299 | $19,26822 claims |
| AbbVieSynthroid | $906 | $2,91922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,150 acute care providers in Florida.
Other acute care in Tampa
- Katrina RileyTampa$66K
- Melissa HamiltonTampa$23K
- Meghan SchmaltzTampa$12K
- Jennifer WicksTampa$8K
- Katherine LanglaisTampa$6K
- Melisa WilsonOrlando$3.6M
- Amanda PeacockJacksonville$81K
- Diane GrayLake Mary$49K
- Heather RamousSafety Harbor$38K
- Melanie WeresJacksonville$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.